AHR three-lens brief
Evidence-based stock research on AHR. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Underperforming SPY by 9.9pp over 30 days. · P/E of 80 — priced for high growth; little margin of safety.
- Underperforming SPY by 9.9pp over 30 days.
- P/E of 80 — priced for high growth; little margin of safety.
- Analyst mean target $64.40 — 19% above current (15 analysts).
- 8-K filing filed 2026-09-02.
AHR closed at $54.06 (+0.54%) as of 2026-09-11. Market cap: $11.79B. P/E (trailing) 79.5. Price is below the 50-day MA and above the 200-day MA. Positives: analyst mean target $64.40 — 19% above current (15 analysts).. Concerns: underperforming SPY by 9.9pp over 30 days.; p/E of 80 — priced for high growth; little margin of safety.. Last quarter: Revenue $674.25M, net income $30.61M, free cash flow $396.68M.
Why three lenses on AHR, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AHRacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/AHR" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AHR brief"></iframe>